Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | DTE Energy Company DTE | Capital Research Global Investors | 17,261,121 7.600% | 17,261,121 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Stifel Financial Corp. SF | Capital Research Global Investors | 5,974,206 5.800% | 5,974,206 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Vale S.A. VALE | Capital Research Global Investors | 294,934,543 5.600% | 294,934,543 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Valvoline Inc. VVV | Capital Research Global Investors | 11,814,917 6.400% | 151,680 (+1.30%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Vector Group Ltd. VGR | Capital Research Global Investors | 18,062,052 8.400% | 18,062,052 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Everi Holdings Inc. EVRI | Capital Research Global Investors | 7,094,959 8.300% | 7,094,959 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital Research Global Investors | 2,605,753 8.800% | 162,839 (+6.67%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Vontier Corporation VNT | Capital Research Global Investors | 9,226,395 5.500% | 9,226,395 (New Position) | Filing History |
| 2021-02-16 1:16 pm Sale | 2021-02-16 | 13G | ENDURANCE INTL GROUP HLDGS INC EIGI | Capital Research Global Investors | 0 0.000% | -11,304,955 (Position Closed) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | EOG Resources, Inc. EOG | Capital Research Global Investors | 70,646,904 12.100% | 24,910,519 (+54.47%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Essent Group Ltd. ESNT | Capital Research Global Investors | 712,000 0.600% | 712,000 (New Position) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital Research Global Investors | 7,261,901 11.000% | 899,206 (+14.13%) | Filing History |
| 2021-02-16 1:16 pm Sale | 2021-02-16 | 13G | Six Flags Entertainment Corporation FUN | Capital Research Global Investors | 0 0.000% | -7,946,163 (Position Closed) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Stanley Black & Decker, Inc. SWK | Capital Research Global Investors | 10,452,773 6.500% | 10,452,773 (New Position) | Filing History |
| 2021-02-16 1:16 pm Sale | 2021-02-16 | 13G | CSX Corporation CSX | Capital Research Global Investors | 156,321,348 6.800% | -6,275,505 (-3.86%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Dayforce Inc DAY | Capital Research Global Investors | 18,108,406 12.300% | 1,289,761 (+7.67%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Thor Industries, Inc. THO | Capital Research Global Investors | 6,781,928 12.200% | 1,114,094 (+19.66%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | Wolfspeed, Inc. CREE | Capital Research Global Investors | 13,517,839 12.300% | 2,607,339 (+23.90%) | Filing History |
| 2021-02-16 1:16 pm Purchase | 2021-02-16 | 13G | TopBuild Corp. BLD | Capital Research Global Investors | 2,586,731 7.800% | 2,586,731 (New Position) | Filing History |
| 2021-02-10 12:30 pm Purchase | 2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital Research Global Investors | 8,024,130 10.200% | 287,382 (+3.71%) | Filing History |